Zydus Cadila's Covid vaccine for children above 12 years gets EUA in India

Zydus Cadila's three-dose ZyCoV-D will be administered through needle free injection system

The world’s first DNA-plasmid vaccine, the three-dose one for Covid-19 developed by Cadila Healthcare (Zydus Cadila), has received emergency-use authorisation from the Drugs Controller General of India (DCGI) for use in adolescents 12 years old and above.

This makes indigenously developed ZyCoV-D India’s first Covid-19 vaccine for this age group, and the vaccine has many firsts. It is based on DNA-plasmid technology; then, it can be administered using a needle-free injection system; and finally, it remains stable in room temperatures for three months.

This is a three-dose vaccine whose second and the third doses are 28 and 56 days, respectively, after the